1.13
price down icon2.59%   -0.03
after-market Handel nachbörslich: 1.12 -0.010 -0.88%
loading
Schlusskurs vom Vortag:
$1.16
Offen:
$1.21
24-Stunden-Volumen:
251.76K
Relative Volume:
0.26
Marktkapitalisierung:
$4.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-6.78M
KGV:
-0.0265
EPS:
-42.6996
Netto-Cashflow:
$-4.67M
1W Leistung:
+16.26%
1M Leistung:
+27.47%
6M Leistung:
-22.07%
1J Leistung:
-32.34%
1-Tages-Spanne:
Value
$1.13
$1.21
1-Wochen-Bereich:
Value
$0.9575
$1.25
52-Wochen-Spanne:
Value
$0.80
$2.18

Clearmind Medicine Inc Stock (CMND) Company Profile

Name
Firmenname
Clearmind Medicine Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
1
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
CMND's Discussions on Twitter

Vergleichen Sie CMND mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
CMND
Clearmind Medicine Inc
1.13 5.23M 0 -6.78M -4.67M -42.70
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Clearmind Medicine Inc Aktie (CMND) Neueste Nachrichten

pulisher
Jul 22, 2025

What analysts say about Clearmind Medicine Inc. stockHigh-yield investments - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Clearmind Medicine Inc. a good long term investmentGame-changing returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Clearmind Medicine Inc. stock priceOutstanding stock performance - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Clearmind Medicine Inc. Stock Analysis and ForecastFree Capital Growth Strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Clearmind Medicine Surges 18.99%: What's Fueling This Volatile Biotech Rally? - AInvest

Jul 21, 2025
pulisher
Jul 20, 2025

How Clearmind Medicine Inc. stock reacts to Fed policy changesFree Access to Community with 300% Return - beatles.ru

Jul 20, 2025
pulisher
Jul 16, 2025

What makes Clearmind Medicine Inc. stock price move sharplySmart Money Trade Setups - beatles.ru

Jul 16, 2025
pulisher
Jul 16, 2025

Clearmind Expands its Clinical Trial for Alcohol Use, New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 16, 2025
pulisher
Jul 15, 2025

How Clearmind Medicine Inc. stock performs during market volatilityFree High-Accuracy Stock Picks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Clearmind Medicine Inc. stock attracts strong analyst attentionTriple Return With Stability - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Expands Its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - MarketScreener

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment By Investing.com - Investing.com South Africa

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind expands phase I/IIa trial for alcohol use disorder treatment - Investing.com India

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 to Johns Hopkins University to Address Alcohol Use Disorder - Nasdaq

Jul 15, 2025
pulisher
Jul 15, 2025

Clearmind Expands its Clinical Trial for Alcohol Use: New Site Activated and Additional Participant Enrolled - The Manila Times

Jul 15, 2025
pulisher
Jul 09, 2025

Clearmind Medicine (NASDAQ:CMND) Stock Price Up 4.5% – Here’s Why - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Alcohol Use Disorder Market Report 2025-2035 Featuring Clearmind Medicine, Purdue Pharma, Psyence Biomedical, Eli Lilly and Co, Tempero Bio,, Nxera Pharma, Novo Nordisk, Adial, Alkermes, Lundbeck - Yahoo Finance

Jul 09, 2025
pulisher
Jul 04, 2025

Clearmind Medicine Soars 32.89% on Clinical Trial Approval - AInvest

Jul 04, 2025
pulisher
Jul 03, 2025

CMND’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial - Nasdaq

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind’s Stock Gains Momentum with New Trial Expansions - timothysykes.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind Medicine’s Rise: What’s Steering the Surge? - timothysykes.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind receives IRB approval for alcohol disorder treatment trial - Investing.com

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind receives IRB approval for alcohol disorder treatment trial By Investing.com - Investing.com South Africa

Jul 03, 2025
pulisher
Jul 03, 2025

Clearmind Medicine Inc. Receives IRB Approval for Phase 1/2a Clinical Trial of CMND-100 for Alcohol Use Disorder - Nasdaq

Jul 03, 2025
pulisher
Jun 30, 2025

Clearmind Medicine Announces First Participant Ever Dosed with its CMND-100 Treatment in Groundbreaking Clinical Trial for Alcohol Use Disorder - The Manila Times

Jun 30, 2025
pulisher
Jun 30, 2025

Clearmind doses first participant in alcohol disorder treatment trial - Investing.com

Jun 30, 2025
pulisher
Jun 30, 2025

Clearmind doses first participant in alcohol disorder treatment trial By Investing.com - Investing.com Canada

Jun 30, 2025
pulisher
Jun 28, 2025

Clearmind Medicine's Global AUD Trial Expansion: Seizing the $775M Market's Psychedelic Opportunity - AInvest

Jun 28, 2025
pulisher
Jun 27, 2025

Clearmind adds Hadassah Medical Center to alcohol disorder drug trial By Investing.com - Investing.com South Africa

Jun 27, 2025
pulisher
Jun 27, 2025

Clearmind Adds New Site to Trial for Experimental Alcohol Use Disorder Drug - MarketScreener

Jun 27, 2025
pulisher
Jun 25, 2025

Clearmind enrolls first patient in CMND-100 alcohol disorder trial - Investing.com India

Jun 25, 2025
pulisher
Jun 25, 2025

Clearmind Medicine Enrolls First Patient in its Clinical Trial for Alcoholism Treatment - Yahoo Finance

Jun 25, 2025
pulisher
Jun 24, 2025

Clearmind Medicine Inc. Engages Consulting Firm to Advance Psychedelic-Based Treatments and Regulatory Advocacy - Nasdaq

Jun 24, 2025
pulisher
Jun 23, 2025

Clearmind adds Tel Aviv medical center to alcohol disorder drug trial - Investing.com India

Jun 23, 2025
pulisher
Jun 23, 2025

Clearmind Medicine Inc. Expands Phase I/IIa Clinical Trial for CMND-100 with Tel Aviv Sourasky Medical Center Collaboration - Nasdaq

Jun 23, 2025
pulisher
Jun 16, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com

Jun 16, 2025
pulisher
Jun 16, 2025

Clearmind Medicine Inc. (NASDAQ:CMND) Short Interest Update - Defense World

Jun 16, 2025

Finanzdaten der Clearmind Medicine Inc-Aktie (CMND)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):